J. Garcia Garcia (Candas (Asturias), Spain), L. Guglielmetti (Paris, France), G. Gualano (Roma (RM), Italy), I. Solovic (Vysne Hagy, Slovakia)
Predictors of tuberculosis in injection drug users
E. Cotelea (Chisinau, Republic of Moldova), E. Lesnic (Chisinau, Republic of Moldova)
|  |
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
O. Komissarova (Moscow, Russian Federation), R. Abdullaev (Moscow, Russian Federation), S. Aleshina (Moscow, Russian Federation)
|  |
Markers of thyroid dysfunction in patients with MDR tuberculosis.
Y. Chumakova (Stavropol, Russian Federation), R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), V. Odinets (Stavropol, Russian Federation)
| |
Transthyretin in patients with pulmonary tuberculosis combined with diabetes
R. Abdullaev (Moscow, Russian Federation), O. Komissarova (Moscow, Russian Federation), O. Berejnaya (Moscow, Russian Federation)
| |
Erectile dysfunction in pulmonary tuberculosis: Is there an association?
a. metwally (Assuit, Egypt), D. Magdy (Assuit, Egypt), R. Ahmed (Assuit, Egypt)
| |
Unusual presentations of tuberculosis in East London
D. Pang (London, United Kingdom), E. Skyllberg (London, United Kingdom), M. Waite (London, United Kingdom), A. Rahman (London, United Kingdom), M. Burman (London, United Kingdom), S. Tiberi (London, United Kingdom), H. Kunst (London, United Kingdom)
| |
Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease.
M. Jakimova (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), O. Gordeeva (Moscow, Russian Federation), R. Asanov (Moscow, Russian Federation)
| |
Prevention and mechanism of undesirable adverse reactions in patients with pulmonary tuberculosis with extensive drug-resistance (XDR) combined with type 2 diabetes
L. Shovkun (Rostov-on-Don, Russian Federation), D. Kudlay (Moscow, Russian Federation), N. Nikolenko (Moscow, Russian Federation), E. Campos (Rostov-on-Don, Russian Federation), I. Franchuk (Rostov-on-Don, Russian Federation)
| |
Study on prevalence and associated factors of Diabetes Mellitus among Tuberculosis Patients in Iran
A. Mozaffari (qom, Islamic Republic of Iran), M. Hendiani (qom, Islamic Republic of Iran)
| |
Influence of diabetes mellitus on sputum conversion rate in pulmonary tuberculosis and on antituberculous drug resistance
B. Paralija (Sarajevo, Bosnia and Herzegovina), A. Mujakovic (Sarajevo, Bosnia and Herzegovina)
| |
Chest radiologic pattern in Diabetic patients with Pulmonary Tuberculosis (PTB)
D. Christopher (Vellore, India), L. Cherian Kuruvilla (Vellore, India), P. Sarangi (Vellore, India), B. Thangakunam (Vellore, India), A. Irodi (Vellore, India), D. Shankar (Vellore, India)
| |
Risk Factors for tuberculosis in patients on anti-TNF treatment
Y. Kaptan (Izmir, Turkey), A. Sunel (Izmir, Turkey), M. Tas (Izmir, Turkey), F. Oksel (Izmir, Turkey), K. Aksu (Izmir, Turkey), A. Sayiner (Izmir, Turkey)
| |
Screening tests for latent tuberculosis prior to anti-TNF alpha therapy – a systematic review and meta-analysis
A. Fonseca Carriço (Guarda, Portugal), A. Ramalho (Porto, Portugal), J. Santos (Porto, Portugal), L. Azevedo (Porto, Portugal), R. Duarte (Porto, Portugal), A. Freitas (Porto, Portugal)
| |
Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy
E. Johnson (London, United Kingdom), K. Shah (London, United Kingdom), A. Rahman (London, United Kingdom), K. Mccafferty (London, United Kingdom), S. Tiberi (London, United Kingdom), H. Kunst (London, United Kingdom)
| |
Tuberculosis of the immunocompromised: what particularities?
H. Kchouk (Ariana, Tunisia), A. Ben Mansour (Ariana, Tunisia), A. Ezzaouia (Ariana, Tunisia), A. Slim (Ariana, Tunisia), S. Ben Saad (Ariana, Tunisia), H. Daghfous (Ariana, Tunisia), F. Tritar (Ariana, Tunisia)
| |
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
R. Angeles (Manila, Philippines), R. King (Manila, Philippines), J. Benedicto (Manila, Philippines), A. Rivera (Manila, Philippines)
| |
Over diagnosis of smear negative pulmonary tuberculosis in patients with allergic bronchopulmonary aspergillosis: A study from high tuberculosis burden country
N. Iqbal (Karachi, Pakistan), M. Irfan (Karachi, Pakistan), U. Riaz (Karachi, Pakistan), S. Saeed (Karachi, Pakistan), M. Amir Sheikh (Karachi, Pakistan), S. Awan (Karachi, Pakistan), A. Zubairi (Karachi, Pakistan)
| |
Adverse effects of anti-tuberculosis drugs in hemodialysis patients
O. Gordeeva (Moscow, Russian Federation), N. Karpina (Moscow, Russian Federation), R. Vedernikova (Moscow, Russian Federation), I. Schultz (Moscow, Russian Federation), A. Bagdasarian (Moscow, Russian Federation)
| |
Cough- and sputum-related quality of life is associated with the features of cavitation in pulmonary tuberculosis
K. Oishi (Shizuoka, Japan), T. Shirai (Shizuoka, Japan), T. Akamatsu (Shizuoka, Japan), T. Suzuki (Shizuoka, Japan), H. Nakayasu (Shizuoka, Japan), K. Tamura (Shizuoka, Japan), T. Masuda (Shizuoka, Japan), S. Takahashi (Shizuoka, Japan), Y. Tanaka (Shizuoka, Japan), Y. Kishimoto (Shizuoka, Japan), Y. Endo (Shizuoka, Japan), M. Saigusa (Shizuoka, Japan), A. Yamamoto (Shizuoka, Japan), S. Morita (Shizuoka, Japan), K. Asada (Shizuoka, Japan)
| |
Side effects of tuberculosis chemotherapy in women of reproductive age: vaginal dysbacteriosis
S. Kayukova (Moscow, Russian Federation), Z. Lulueva (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), A. Ergeshov (Moscow, Russian Federation)
| |